Immune profiling of responses to influenza vaccination in patients with myeloproliferative neoplasms
Open Access
Abstract
Myeloproliferative neoplasms (MPNs) are associated with immune dysregulation and increased susceptibility to infection, emphasizing the importance of vaccination for patients. This pilot study evaluated immune responses to influenza vaccination in MPN patients compared with healthy donors using mass cytometry and serology. We observed diminished CXCR5+ B‐cell, CXCR3+ T‐cell, activated CD127+ memory T‐cell subsets, and a trend toward lower hemagglutinin inhibition titer in MPN patients. These results indicate that patients with MPN exhibit distinct responses to influenza vaccination suggestive of impaired migration to lymphoid organs and T‐cell maturation which may impact the development of protective immunity.Keywords
This publication has 15 references indexed in Scilit:
- Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotypeMedical Oncology, 2022
- Addressing symptom burden in myeloproliferative neoplasmsBest Practice & Research Clinical Haematology, 2022
- Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancersPLOS ONE, 2022
- The Expression of Active CD11b Monocytes in Blood and Disease Progression in Amyotrophic Lateral SclerosisInternational Journal of Molecular Sciences, 2022
- Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasmsBritish Journal of Haematology, 2020
- UMAP: Uniform Manifold Approximation and ProjectionJournal of Open Source Software, 2018
- Seasonal influenza vaccine in immunocompromised personsHuman Vaccines & Immunotherapeutics, 2018
- CXCR3 in T cell functionExperimental Cell Research, 2011
- Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulationNature Immunology, 2009
- Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosusArthritis Research & Therapy, 2005